Its knockout significantly expands the TCF-1+ TPEX cell pool, enhances memory-like differentiation and secondary response capacity, thereby markedly improving tumor clearance efficacy and long-term persistence of CAR-T cells in B-ALL models [81]. This evidence concerns the gene TCF7 and neoplasm.